A. Menarini India is the Indian affiliate of the Menarini Group, which is a leading biopharmaceutical company, focused on delivering differentiated ethical and consumer healthcare brands across the world. A. Menarini India operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management and offers an unparalleled customer experience to all stakeholders including partners wanting to tap into the India growth story.
Through our team of over 1,200 passionate sales, marketing and support professionals, A. Menarini India manages a diverse portfolio of proprietary healthcare brands as well as licensed brands from global biotech and multinational companies. Leveraging the strengths of its infrastructure, A. Menarini India is able to tap onto extensive global resources and its' own unique local customer insights to deliver innovative brands from R&D, through to manufacturing, regulatory approvals and commercialisation.
A. Menarini India operates in one of the fastest growing healthcare markets worldwide, increasing at an annual compounded growth rate of 15 percent*, more than double the global growth rate for the sector. With India being among the top growth contributors globally, A. Menarini India is establishing itself as a leader in this rapidly expanding market through targeted investments.
With over 3,300 professionals in 13 major markets, Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management and offers an unparalleled customer experience to partners wanting to tap into the Asia-Pacific growth story.
*For 2013-14 period as per IMS Q1 2014
Invida was formed in 2005 by a powerful strategic partnership of Quintiles, the world's leading pharmaceutical services organization; Temasek Holdings, one of the world's largest investment companies, and Zuellig Group, the largest pharmaceutical distribution and supply chain management network in Asia Pacific.
On 11 November 2011, Italy based Menarini Group successfully bid and acquired Invida Group, a strategic move that was poised to allow both companies and its partners to have a stronger presence in the Asia Pacific region. With 17,000 employees and an annual revenue exceeding USD 4.4 billion in 2012, Menarini is the largest Italian pharmaceutical group and ranks 34th out of 14,051 pharmaceutical companies in the world.
Following this acquisition Invida India changed its name to A. Menarini India and carries with it the history, relationships and strong track record with of its strategic partners. The subsidiaries of Menarini, Pharmalink, Inovail and Innovex, had been present in the market from 1960s and have been integrated into a single global brand, Menarini, to serve the rapidly growing needs of its global partners and stakeholders. A. Menarini India was first established in 2002 as Innovex, the erstwhile CSO arm of Quintiles. In 2005, the company was renamed Pharmalink and subsequently, to Invida in 2010 as part of a companywide initiative to unify its stable of brands into a single global brand. In May 2013 Invida was renamed as Menarini India.